KENDALL IZZO: Open Payments
NPI 1033727417 · CHILLICOTHE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,645 in 167 payments from 13 companies in 2025. Trend: 2023 $149 · 2024 $3,036 · 2025 $4,645
Food & beverage: $4,533Education: $111
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $671 |
| Alkermes, Inc. | 25 | $566 |
| Vanda Pharmaceuticals Inc. | 19 | $542 |
| ABBVIE INC. | 28 | $526 |
| E.R. Squibb & Sons, L.L.C. | 19 | $474 |
| Neurocrine BioSciences, Inc. | 15 | $467 |
| Teva Pharmaceuticals USA, Inc. | 13 | $437 |
| Otsuka America Pharmaceutical, Inc. | 20 | $361 |
| Axsome Therapeutics, Inc. | 5 | $305 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $176 |
Products named: VRAYLAR, COBENFY, INGREZZA, INVEGA SUSTENNA, ARISTADA, FANAPT, Auvelity, REXULTI.
Industry payments across OH — which companies pay providers there.
